Henry M, Amor M, Cragg A, Porte J M, Henry I, Amicabile C, Tricoche O
Interventional Cardiac and Surgery Unit, Polyclinic Essey Les Nancy, France.
Radiology. 1996 Dec;201(3):717-24. doi: 10.1148/radiology.201.3.8939221.
To assess the use of a recently developed stent-graft system for treatment of occlusive lesions and aneurysms in the iliac and femoropopliteal arteries.
The stent-graft consisted of a nitinol stent framework covered by a thin-walled polyester fabric. The device was used in 105 patients with symptomatic peripheral vascular disease. Implant locations were iliac artery (n = 38), femoral artery (n = 62), and popliteal artery (n = 5).
Initial technical success was achieved in all patients except one with occlusive disease and one with aneurysmal disease. Residual stenosis after stent-graft implantation was 0.5% +/- 3. Mean ankle-brachial index increased from 0.53 to 0.98. Complications were hematoma (n = 3), pseudoaneurysm (n = 2), puncture site thrombosis (n = 1), early graft thrombosis (n = 8), graft misplacement (n = 1), distal embolization (n = 2), delayed thrombosis (n = 14), pain and fever (n = 27). At the iliac level, primary patency was 97% and secondary patency was 100%. At the femoral level, primary patency was 59% and secondary patency was 81%.
Endoluminal bypass with a percutaneously delivered stent-graft is feasible. Technical results are good, and the number of complications is few at the iliac level. At the femoropopliteal level, patency is not as good and the number of complications is higher.
评估一种最近开发的支架移植物系统用于治疗髂动脉和股腘动脉闭塞性病变及动脉瘤的效果。
该支架移植物由镍钛诺支架框架和薄壁聚酯织物覆盖物组成。该装置用于105例有症状的外周血管疾病患者。植入部位为髂动脉（n = 38）、股动脉（n = 62）和腘动脉（n = 5）。
除1例闭塞性疾病患者和1例动脉瘤疾病患者外，所有患者均取得了初步技术成功。支架移植物植入后的残余狭窄为0.5%±3%。平均踝肱指数从0.53增加到0.98。并发症包括血肿（n = 3）、假性动脉瘤（n = 2）、穿刺部位血栓形成（n = 1）、早期移植物血栓形成（n = 8）、移植物错位（n = 1）、远端栓塞（n = 2）、延迟血栓形成（n = 14）、疼痛和发热（n = 27）。在髂动脉水平，原发性通畅率为97%，继发性通畅率为100%。在股动脉水平，原发性通畅率为59%，继发性通畅率为81%。
经皮输送的支架移植物进行腔内旁路术是可行的。技术效果良好，在髂动脉水平并发症数量较少。在股腘动脉水平，通畅率不太理想且并发症数量较多。
